D.E. Shaw & Co
BVS icon

D.E. Shaw & Co’s Bioventus BVS Stock Holding History

D.E. Shaw & Co’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Sell
47,304
-263,306
-85% -$2.51M ﹤0.01% 4235
2026
Q1 		$2.84M Sell
310,610
-47,647
-13% -$400K ﹤0.01% 2640
2025
Q4 		$2.67M Buy
358,257
+169,365
+90% +$1.22M ﹤0.01% 2816
2025
Q3 		$1.26M Buy
188,892
+118,450
+168% +$822K ﹤0.01% 3306
2025
Q2 		$466K Sell
70,442
-97,309
-58% -$690K ﹤0.01% 3672
2025
Q1 		$1.53M Buy
167,751
+7,095
+4% +$70.9K ﹤0.01% 2802
2024
Q4 		$1.69M Sell
160,656
-160,974
-50% -$1.9M ﹤0.01% 2850
2024
Q3 		$3.84M Buy
321,630
+124,455
+63% +$1.08M ﹤0.01% 2162
2024
Q2 		$1.13M Buy
+197,175
New +$1.08M ﹤0.01% 3105
2024
Q1 		– Sell
-35,910
Closed -$189K – 4365
2023
Q4 		$189K Buy
+35,910
New +$142K ﹤0.01% 3892
2023
Q2 		– Sell
-18,300
Closed -$19.6K – 4259
2023
Q1 		$19.6K Buy
18,300
+5,700
+45% +$10.9K ﹤0.01% 4147
2022
Q4 		$32.9K Buy
+12,600
New +$55K ﹤0.01% 4472
2021
Q4 		– Sell
-15,024
Closed -$213K – 5416
2021
Q3 		$213K Buy
+15,024
New +$231K ﹤0.01% 4538

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co's BVS Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Bioventus (BVS) stake by 85% in Q2 2026, selling an estimated $2.51M and leaving 47,304 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #4235.

D.E. Shaw & Co first reported a position in BVS in Q3 2021 and has held it in 13 quarters since. The position peaked at $3.84M in Q3 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • D.E. Shaw & Co held 47,304 shares of Bioventus worth $447K as of Q2 2026.
  • D.E. Shaw & Co sold 263,306 Bioventus shares in Q2 2026, an estimated $2.51M.
  • Bioventus made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #4235 holding.
  • D.E. Shaw & Co first reported a position in Bioventus in Q3 2021 and has held it in 13 quarters since.
  • D.E. Shaw & Co's Bioventus position peaked at $3.84M in Q3 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.